The trade-off is a very short half-life of approximately 20-30 minutes after subcutaneous injection, making it unsuitable for systemic use and largely studied in local tissue applications [10]
Alkaloid antioxidant berberine was recently reported to exert positive effects in treating GD
Thus, a burgeoning question in the obesity drug field is whether weight-lowering drugs target separate aversive or non-aversive pathways in the brain to suppress food intake
Its role in the formulation supports gut-brain health , connecting stress response, inflammatory balance, mental clarity, and metabolic wellness (Lopresti et al., 2019)
More conservative dose limits, such as 2000 mg per day, have been recommended, especially for patients in whom the liver disease is marked with hepatic decompensation or active alcohol abuse